Somatrogon for treating growth disturbance in children and young people aged 3 years and over (TA863)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 1 February 2023
Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiency (HST7)Product type:GuidanceProgramme:Highly specialised technologies guidancePublished: 7 February 2018
Faltering growth: recognition and management of faltering growth in children (NG75)Product type:GuidanceProgramme:NICE guidelinePublished: 27 September 2017
Human growth hormone (somatropin) for the treatment of growth failure in children (TA188)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 May 2010